SweetValueLab
Write for us

Becton, Dickinson and Company — Financial Statements & Ratios

BDX
NYSEHealthcareMedical - Instruments & SuppliesCIK 0000010795bd.comAbout BDX
Last close · Oct 16, 2026191.75−2.01 (−1.04%)
Market cap$52.2B

Key indicators

Revenue20.8BTTM−2.6% on a year earlier+4.6% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
16.0B 17.3B+8.2%17.1B−1.0%20.2B+18.3%18.9B−6.8%19.4B+2.7%20.2B+4.2%21.8B+8.2%20.8B−2.6%19.3B 19.7B 20.5B
— 8.2% -1.0% 18.3% -6.8% 2.7% 4.2% 8.2% -2.6% -11.6% 2.1% 3.9%
$0.60 $3.94+556.7%$2.71−31.2%$6.85+152.8%$5.88−14.2%$4.94−16.0%$5.86+18.6%$5.82−0.7%$3.31−39.6%$12.67 $13.24 $14.16
Profitability
45.4% 47.9%+2.5 pt44.3%−3.7 pt— — — — — — · · ·
9.4% 10.2%+0.8 pt8.7%−1.5 pt13.8%+5.2 pt12.1%−1.7 pt10.9%−1.2 pt11.9%+1.0 pt11.8%−0.1 pt9.6%−2.1 pt· · ·
1.9% 7.1%+5.2 pt5.1%−2.0 pt10.3%+5.2 pt9.4%−0.9 pt7.7%−1.8 pt8.4%+0.8 pt7.7%−0.8 pt4.5%−2.9 pt· · ·
1.5% 5.8%+4.4 pt3.7%−2.2 pt8.8%+5.2 pt7.0%−1.8 pt5.8%−1.3 pt6.6%+0.8 pt6.6%+0.0 pt— · · ·
Cash
2.0B 2.4B+20.5%2.7B+15.0%3.4B+25.2%1.5B−56.1%2.1B+41.3%3.1B+47.4%2.7B−14.4%— · · ·
12.3% 13.7%+1.4 pt15.9%+2.2 pt16.9%+0.9 pt7.9%−8.9 pt10.9%+3.0 pt15.5%+4.5 pt12.2%−3.2 pt— · · ·
927.0M 984.0M+6.1%1.0B+4.3%1.0B+2.1%1.1B+3.2%1.1B+3.0%1.1B−1.3%1.2B+8.7%— · · ·
Balance sheet
1.02x 0.92x−0.10x0.75x−0.17x0.74x−0.01x0.64x−0.11x0.62x−0.02x0.78x+0.16x0.76x−0.02x0.69x−0.07x· · ·
264.62M 274.77M+3.8%282.40M+2.8%292.09M+3.4%287.36M−1.6%288.39M+0.4%291.01M+0.9%288.51M−0.9%275.16M−4.2%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.